Nisa Investment Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,080
Closed -$55.1K 3082
2024
Q4
$55.1K Buy
1,080
+27
+3% +$1.33K ﹤0.01% 1658
2024
Q3
$43.4K Buy
1,053
+97
+10% +$4.66K ﹤0.01% 1677
2024
Q2
$46K Buy
956
+435
+83% +$19.3K ﹤0.01% 1697
2024
Q1
$25K Buy
521
+25
+5% +$1.33K ﹤0.01% 1825
2023
Q4
$32.2K Sell
496
-693
-58% -$41.7K ﹤0.01% 1737
2023
Q3
$77.8K Buy
1,189
+693
+140% +$43.6K ﹤0.01% 1589
2023
Q2
$28.8K Sell
496
-719
-59% -$45.4K ﹤0.01% 1955
2023
Q1
$75K Sell
1,215
-181
-13% -$10.9K ﹤0.01% 1595
2022
Q4
$89K Buy
1,396
+8
+0.6% +$580 ﹤0.01% 1588
2022
Q3
$106K Buy
1,388
+388
+39% +$28.9K ﹤0.01% 1483
2022
Q2
$68K Buy
1,000
+122
+14% +$8.77K ﹤0.01% 1626
2022
Q1
$80K Sell
878
-102
-10% -$8.35K ﹤0.01% 1700
2021
Q4
$72K Sell
980
-870
-47% -$74.6K ﹤0.01% 1627
2021
Q3
$150 Buy
1,850
+1,500
+429% +$126K ﹤0.01% 1528
2021
Q2
$33 Buy
+350
New +$33.9K ﹤0.01% 2034

Other funds holding NARI

Nisa Investment Advisors's NARI Position: Q1 2025 in Review

Nisa Investment Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,080 shares — an estimated $55.1K sold.

Nisa Investment Advisors first reported a position in NARI in Q2 2021 and held it in 15 quarters. The position peaked at $106K in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Nisa Investment Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,080 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $55.1K.
  • Nisa Investment Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Nisa Investment Advisors's Inari Medical, Inc. Common Stock position peaked at $106K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Nisa Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.